APPLICATION
ANDA088237
TYPE
ANDA
ORIGINAL APPROVAL
1983-04-28
LATEST ACTION
2024-07-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
DEXAMETHASONEDiscontinued
DEXAMETHASONE 1.5MG · TABLET · ORAL
Approval history
2024-07-01Labeling · Supplement 30 · standardAP
2008-07-24Labeling · Supplement 26AP
1997-11-26Manufacturing (CMC) · Supplement 23AP
1997-11-26Manufacturing (CMC) · Supplement 24AP
1995-10-30Labeling · Supplement 22AP
1994-04-28Labeling · Supplement 21AP
1992-04-29Labeling · Supplement 20AP
1990-11-20Labeling · Supplement 19AP
1990-01-23Labeling · Supplement 18AP
1989-07-31Labeling · Supplement 17AP
1988-09-16Manufacturing (CMC) · Supplement 16AP
1986-05-01Manufacturing (CMC) · Supplement 14AP
1986-05-01Manufacturing (CMC) · Supplement 12AP
1984-02-27Manufacturing (CMC) · Supplement 5AP
1984-02-27Manufacturing (CMC) · Supplement 3AP
1984-02-27Manufacturing (CMC) · Supplement 6AP
1984-02-27Manufacturing (CMC) · Supplement 2AP
1983-12-06Manufacturing (CMC) · Supplement 9AP
1983-10-04Manufacturing (CMC) · Supplement 7AP
1983-04-28OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.